$16.98
-0.80-4.50%
At close: -
$16.98
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
AnaptysBio Earnings Estimates, EPS & Revenue | NASDAQ:ANAB | Benzinga
AnaptysBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-1.460
Quarterly Revenue Estimate
$15.27M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$91.28M
Analyze the earnings history of AnaptysBio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANAB | AnaptysBio | -$1.64 | -$1.46 | — | — | $7.18M | $15.27M | — | — | 05/08/2025 | Get Alert |
| ANAB | AnaptysBio | -$1.59 | -$1.74 | -$0.72 | 58.62% | $9.01M | $10.09M | $43.11M | 327.28% | 02/27/2025 | Get Alert |
| ANAB | AnaptysBio | -$1.41 | -$1.65 | -$1.14 | 30.91% | $3.32M | $6.87M | $30.02M | 336.74% | 11/05/2024 | Get Alert |
| ANAB | AnaptysBio | -$1.50 | -$0.89 | -$1.71 | -92.13% | $3.46M | $24.30M | $10.97M | -54.85% | 08/05/2024 | Get Alert |
| ANAB | AnaptysBio | -$1.58 | -$1.56 | -$1.64 | -5.13% | $1.37M | $3.72M | $7.18M | 92.98% | 05/09/2024 | Get Alert |
| ANAB | AnaptysBio | -$0.93 | -$1.60 | -$1.59 | 0.63% | $6.81M | $2.23M | $9.01M | 303.81% | 03/11/2024 | Get Alert |
| ANAB | AnaptysBio | -$1.18 | -$1.79 | -$1.41 | 21.23% | $1.29M | $2.51M | $3.32M | 32.19% | 11/02/2023 | Get Alert |
| ANAB | AnaptysBio | -$1.15 | -$1.70 | -$1.50 | 11.76% | $1.22M | $3.32M | $3.46M | 4.22% | 08/07/2023 | Get Alert |
| ANAB | AnaptysBio | -$1.31 | -$1.05 | -$1.58 | -50.48% | $970.00K | $3.57M | $1.37M | -61.51% | 05/11/2023 | Get Alert |
| ANAB | AnaptysBio | -$1.18 | -$0.97 | -$0.93 | 4.12% | $1.01M | $6.83M | $6.81M | -0.32% | 03/01/2023 | Get Alert |
| ANAB | AnaptysBio | -$0.24 | -$0.72 | -$1.18 | -63.89% | $20.89M | $10.34M | $1.29M | -87.50% | 11/08/2022 | Get Alert |
| ANAB | AnaptysBio | -$0.02 | -$1.04 | -$1.15 | -10.58% | $30.03M | — | $1.22M | — | 08/08/2022 | Get Alert |
| ANAB | AnaptysBio | -$0.66 | -$0.99 | -$1.31 | -32.32% | $11.25M | $5.05M | $970.00K | -80.79% | 05/04/2022 | Get Alert |
| ANAB | AnaptysBio | $1.20 | $2.57 | -$1.13 | -143.97% | $60.00M | $110.88M | $1.01M | -99.09% | 03/07/2022 | Get Alert |
| ANAB | AnaptysBio | -$0.87 | -$0.91 | -$0.24 | 73.63% | $0.00 | $6.67M | $20.89M | 213.19% | 11/04/2021 | Get Alert |
| ANAB | AnaptysBio | -$0.79 | -$0.11 | -$0.02 | 81.82% | $0.00 | $28.88M | $30.03M | 3.97% | 08/09/2021 | Get Alert |
| ANAB | AnaptysBio | -$0.30 | -$0.69 | -$0.66 | 4.35% | $15.00M | $9.39M | $11.25M | 19.78% | 05/04/2021 | Get Alert |
| ANAB | AnaptysBio | -$0.75 | $1.39 | $1.20 | -13.67% | $3.00M | $64.00M | $60.00M | -6.25% | 02/25/2021 | Get Alert |
| ANAB | AnaptysBio | -$1.15 | -$0.72 | -$0.87 | -20.83% | $0.00 | $1.67M | $0.00 | -100.00% | 11/04/2020 | Get Alert |
| ANAB | AnaptysBio | -$0.89 | -$0.75 | -$0.79 | -5.33% | $5.00M | $2.32M | $0.00 | -100.00% | 08/10/2020 | Get Alert |
| ANAB | AnaptysBio | -$0.82 | — | -$0.30 | — | $0.00 | — | $15.00M | — | 05/06/2020 | Get Alert |
AnaptysBio (ANAB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.72 | $-1.74 | 58.6 % |
| Q3 | 2024-11-05 | $-1.14 | $-1.65 | 30.9 % |
| Q2 | 2024-08-05 | $-1.71 | $-0.89 | -92.1 % |
| Q1 | 2024-05-09 | $-1.64 | $-1.56 | -5.13 % |
AnaptysBio (ANAB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $43.11M | $10.09M | 327.3 % |
| Q3 | 2024-11-05 | $30.02M | $6.87M | 336.7 % |
| Q2 | 2024-08-05 | $10.97M | $24.30M | -54.9 % |
| Q1 | 2024-05-09 | $7.18M | $3.72M | 93.0 % |
FAQ
When is AnaptysBio (NASDAQ:ANAB) reporting earnings?
AnaptysBio (ANAB) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for AnaptysBio (NASDAQ:ANAB)?
The Actual EPS was $-0.72, which beat the estimate of $-1.74.
What were AnaptysBio’s (NASDAQ:ANAB) revenues?
The Actual Revenue was $43.1M, which beat the estimate of $10.1M.
Browse earnings estimates, EPS, and revenue on all stocks.